Y-mAbs Therapeutics, Inc.

Delisted

CIK 1722964fmd_0E8DAJC6A7ZN0E0V4PVRDQCYEBManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2016 to Jun 30, 2025, 35 periods

News summary

An AI model writes the summary on request, from this company's recent filings only, and cites each filing it uses.

AI-written

Event typeImportance0 filings

From 8-K filings, not wire news: the items each filer selected on the EDGAR cover, grouped by event type. Importance is FinancialMD's own rule by item number (5: bankruptcy, non-reliance, change of control, delisting, cybersecurity; 1: exhibits only).